4.1 Review

Alamandine: Potential Protective Effects in SARS-CoV-2 Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Alamandine via MrgD receptor attenuates pulmonary fibrosis via NOX4 and autophagy pathway

Qingxia Liu et al.

Summary: ALA reduces oxidative injury and induces autophagy through the MrgD receptor, alleviating pulmonary fibrosis.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2021)

Review Immunology

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

Chris R. Triggle et al.

Summary: Although significant progress has been made in understanding the mechanics of virus transmission and the immune response, there are still unanswered questions about reinfection, susceptibility of the elderly, and whether asymptomatic children contribute to transmission. Uncertainties remain regarding the pathophysiology of COVID-19, variations in clinical presentations, and the phenomenon of long haulers. Currently, there are no highly effective drugs for treating COVID-19, with trials of hydroxychloroquine proving unsuccessful. Remdesivir has shown some success in aiding recovery of severely ill patients, but does not reduce mortality like dexamethasone. However, vaccine development has seen substantial advancements, with several vaccines being approved for use globally.

FRONTIERS IN IMMUNOLOGY (2021)

Article Toxicology

Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats

Ava Soltani Hekmat et al.

Summary: Alamandine co-therapy can prevent DOX-induced cardiotoxicity by enhancing endogenous antioxidants and anti-inflammatory effects, resulting in reduced oxidative stress, inflammatory cytokines, and apoptosis in rat models.

HUMAN & EXPERIMENTAL TOXICOLOGY (2021)

Review Virology

Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19

Shibi Muralidar et al.

Summary: SARS-CoV-2 is the causative agent of COVID-19, and targeting key steps of viral entry like the interaction between S-protein and ACE2 is crucial for developing effective therapeutics. Studies have shown the importance of cell surface heparan sulfate, TMPRSS2, and CatB/L in mediating SARS-CoV-2 entry, providing potential targets for drug development.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Pharmacology & Pharmacy

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19

Annamaria Mascolo et al.

Summary: The renin-angiotensin-aldosterone system (RAAS) is now recognized as a local tissue system that affects organ function and can contribute to the onset of diseases. It operates in both the heart and lungs, with classic and non-classic pathways having different effects on cardiovascular and pulmonary health.

FRONTIERS IN PHARMACOLOGY (2021)

Review Medicine, General & Internal

Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

Hawraa Issa et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has become a major global health concern. The differential response to SARS-CoV-2 is correlated with the expression of ACE2, and using ACE2 soluble analogs may be a safer treatment option. While ACE2 inhibitors and antibodies can block viral entry, they may also exacerbate lung and cardiovascular pathology.

FRONTIERS IN MEDICINE (2021)

Article Food Science & Technology

Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective

Shivraj Hariram Nile et al.

Summary: This review discusses various potential therapies for COVID-19 utilizing a range of compounds, including small molecules, bioactive compounds, nucleoside and nucleotide analogs, peptides, antibodies, natural products, and synthetic compounds targeting the molecular signaling network involved in the disease. More than 230 natural and chemically synthesized drug therapies are described, focusing on recent advances in research and development of their chemical, structural, and functional properties for possible novel therapeutic targets against SARS-CoV-2.

FOOD AND CHEMICAL TOXICOLOGY (2021)

Editorial Material Medicine, General & Internal

IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19 Who, When, and How?

Michael A. Matthay et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Respiratory System

Contemporary narrative review of treatment options for COVID-19

Lianhan Shang et al.

Summary: The COVID-19 pandemic is ongoing, with many drugs being studied in clinical trials. Different drugs may be more effective at different stages of infection. Some drugs have shown benefits in certain groups of COVID-19 patients, while others have been proven ineffective.

RESPIROLOGY (2021)

Article Pharmacology & Pharmacy

Protective effect of alamandine on doxorubicin-induced nephrotoxicity in rats

Ava Soltani Hekmat et al.

Summary: This study demonstrated that alamandine can protect against doxorubicin-induced nephrotoxicity in rats by reducing pro-inflammatory cytokines and pro-fibrotic proteins levels, as well as preserving renal function.

BMC PHARMACOLOGY & TOXICOLOGY (2021)

Article Peripheral Vascular Disease

Assessment of Alamandine in Pulmonary Fibrosis and Respiratory Mechanics in Rodents

Renata Streck Fernandes et al.

Summary: Treatment with ALA can attenuate the progression of PF, improve respiratory system mechanics, and maintain weight gain in fibrotic animals.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2021)

Letter Respiratory System

Increased circulating levels of angiotensin-(1-7) in severely ill COVID-19 patients

Ana Lanza Valle Martins et al.

ERJ OPEN RESEARCH (2021)

Review Infectious Diseases

Role of Serine Proteases and Host Cell Receptors Involved in Proteolytic Activation, Entry of SARS-CoV-2 and Its Current Therapeutic Options

Gashaw Dessie et al.

Summary: The current global pandemic of the novel coronavirus has caused a public health disaster, with millions of deaths worldwide. Despite efforts in vaccine development and candidate drug design, there is no well-defined therapy for prevention, making the complete prevention of the virus challenging. Ongoing clinical trials and research are focusing on understanding the mechanisms of virus entry and activation, as well as exploring therapeutic options for SARS-CoV-2.

INFECTION AND DRUG RESISTANCE (2021)

Article Biochemistry & Molecular Biology

Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity

Sandipan Chakraborty

Summary: This study identified SARS-CoV2 spike variants through evolutionary analysis, revealing five RBD variants under strong positive selection bias. Among these variants, three showed reduced binding affinity to ACE2, while the other two displayed higher binding affinity towards human ACE2. The enhanced binding affinity was attributed to reorientation of crucial residues at the RBD-ACE2 interface and strong interfacial complementarity between the RBD and ACE2.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Annamaria Mascolo et al.

HEART FAILURE REVIEWS (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Editorial Material Cardiac & Cardiovascular Systems

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Gabriela M. Kuster et al.

EUROPEAN HEART JOURNAL (2020)

Article Medicine, General & Internal

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19

Harmony R. Reynolds et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19

Muthiah Vaduganathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Elevated Angiotensin 1-7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients With Heart Failure

Kaiming Wang et al.

CIRCULATION-HEART FAILURE (2020)

Article Infectious Diseases

Urgent need for evaluating agonists of angiotensin-(1-7)/Mas receptor axis for treating patients with COVID-19

Ashwini Shete

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Review Biochemistry & Molecular Biology

COVID-19 and Oxidative Stress

B. Chernyak et al.

BIOCHEMISTRY-MOSCOW (2020)

Review Medicine, Research & Experimental

ACE2 in the renin-angiotensin system

Thiago Verano-Braga et al.

CLINICAL SCIENCE (2020)

Review Immunology

Controlling Cytokine Storm Is Vital in COVID-19

Lu Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be

Giuseppina Mariano et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Critical Care Medicine

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

Wentao Ni et al.

CRITICAL CARE (2020)

Editorial Material Cardiac & Cardiovascular Systems

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Gabriela M. Kuster et al.

EUROPEAN HEART JOURNAL (2020)

Article Medicine, Research & Experimental

Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice

Fernando Pedro de Souza-Neto et al.

CLINICAL SCIENCE (2019)

Article Cell Biology

Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages In Vitro and In Vivo

Melissa de Carvalho Santuchi et al.

MEDIATORS OF INFLAMMATION (2019)

Article Cell Biology

Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes

Itamar Couto Guedes de Jesus et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Alamandine Protects the Heart Against Reperfusion Injury via the MrgD Receptor

Byung Mun Park et al.

CIRCULATION JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure

Francesco Rossi et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanisms

Tawar Qaradakhi et al.

CARDIOVASCULAR THERAPEUTICS (2017)

Article Medicine, Research & Experimental

Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies

Seema Patel et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Cardiac & Cardiovascular Systems

Differences in Cardiovascular Responses to Alamandine in Two-Kidney, One Clip Hypertensive and Normotensive Rats

Ava Soltani Hekmat et al.

CIRCULATION JOURNAL (2017)

Review Cardiac & Cardiovascular Systems

Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Mark C. Chappell

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)

Review Pharmacology & Pharmacy

Angiotensin (1-7) and Alamandine: Similarities and differences

Tawar Qaradakhi et al.

PHARMACOLOGICAL RESEARCH (2016)

Review Urology & Nephrology

Alamandine: a new member of the angiotensin family

Daniel C. Villela et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)

Article Cardiac & Cardiovascular Systems

Discovery and Characterization of Alamandine A Novel Component of the Renin-Angiotensin System

Roberto Queiroga Lautner et al.

CIRCULATION RESEARCH (2013)

Article Cell Biology

Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats

Yogendra Singh et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)

Article Physiology

Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells

George C. Liu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)